Key Insights

Highlights

Success Rate

86% trial completion

Published Results

11 trials with published results (48%)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

13.0%

3 terminated out of 23 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

65%

15 trials in Phase 3/4

Results Transparency

61%

11 of 18 completed with results

Key Signals

11 with results86% success

Data Visualizations

Phase Distribution

21Total
P 1 (1)
P 2 (5)
P 3 (11)
P 4 (4)

Trial Status

Completed18
Terminated3
Withdrawn2

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 18 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT00152451Phase 2CompletedPrimary

Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

NCT00150709Phase 3CompletedPrimary

A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With Epilepsy

NCT00152503Phase 2CompletedPrimary

Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking Levetiracetam

NCT00280059Phase 3CompletedPrimary

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

NCT00175890Phase 3CompletedPrimary

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

NCT00160654Phase 4CompletedPrimary

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

NCT00160615Phase 3CompletedPrimary

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

NCT01691872Phase 1WithdrawnPrimary

Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian Subjects

NCT01891890Phase 3TerminatedPrimary

Cognitive AED Outcomes in Pediatric Localization Related Epilepsy (COPE)

NCT01375374Phase 3TerminatedPrimary

Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to Lacosamide

NCT00355082Phase 3CompletedPrimary

Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy

NCT00113165Phase 3Completed

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

NCT00105040Phase 2CompletedPrimary

A 19-week Cognition Study of Levetiracetam in Children With Partial Onset Seizures

NCT02220972Phase 4WithdrawnPrimary

To Evaluate the Effect of Perampanel on Objective and Subjective Sleep in Subjects With Insomnia and Partial Onset Seizures

NCT01545518Phase 2Terminated

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

NCT00152373Phase 3CompletedPrimary

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

NCT00160628Phase 3CompletedPrimary

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

NCT00245713Phase 4CompletedPrimary

Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.

NCT00643500Phase 4CompletedPrimary

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT01332539CompletedPrimary

An Observational Study to Assess the Burden of Drug-resistant Partial Epilepsy in Italy

Scroll to load more

Research Network

Activity Timeline